Reference Source

Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.

66794-160-02 · Morphine Sulfate Injection · Piramal Critical Care Inc.

What is the package ndc for 66794-160-02 · Morphine Sulfate Injection · Piramal Critical Care Inc.?

For 66794-160-02 · Morphine Sulfate Injection · Piramal Critical Care Inc., package ndc is 66794-160-02; generic name is Morphine Sulfate Injection; manufacturer is Piramal Critical Care Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.

"initial_posting_date": "10/31/2017", "package_ndc": "66794-160-02", "generic_name": "Morphine Sulfate Injection", "contact_info": "800-414-1901", "availability": "Limited Availability", "related_info": "On allocation"

api.fda.gov, retrieved 2026-09-01

Package NDC
66794-160-02 verified
Generic name
Morphine Sulfate Injection verified
Manufacturer
Piramal Critical Care Inc. verified
Status
Current verified
Availability now
Limited Availability verified
FDA note
On allocation verified
Initial posting date
10/31/2017 verified
Last update date
08/04/2026 verified
Days in shortage
3227 our reading
Reason for shortage
Demand increase for the drug verified
Dosage form
Injection verified
Therapeutic category
Analgesia/Addiction verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/04/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)", "company_name": "Piramal Critical Care Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.